Different European Perspectives on the Treatment of Subclinical Mastitis in Dairy Cows



mastitis, subclinical bovine mastitis, lactational treatment, treatment approaches, Europe, ENOVAT


As part of the European Network for Optimization of Veterinary Antimicrobial Treatment (ENOVAT), a webinar on the topic "Different European Perspectives on the Treatment of Subclinical Mastitis in Lactation" was held on September 21, 2022, during which eight mastitis experts from different European countries (France, Hungary, Italy, the Netherlands, Portugal, Slovenia, Sweden, and the United Kingdom) presented their treatment approaches for subclinical mastitis during lactation. The information provided by the experts is based on experience, guidelines, surveys, and opinions of the university to which they belong. The aim of this study was to compare the therapeutic approaches to identify commonalities and differences. It was not the aim of the webinar to identify the best approach for the treatment of subclinical mastitis, but to better understand the different approaches in the different countries in order to find starting points for long-term harmonization.

The definition of subclinical mastitis varies from country to country. However, in all countries the definition is based on the presence of increased somatic cell count (SCC) in the quarter milk but without clinical signs or visual changes in the milk and is usually caused by an intramammary infection (IMI). Particularly regarding the cell count limit, the definitions differ between countries. In all participating countries, treatment of subclinical mastitis is not standard practice. This varies from a general rejection of treatment during lactation to treatment in special situations, involving the risk of penalties if a certain threshold of cells in the bulk tank milk is exceeded. Diagnostically, in its simplest form, subclinical mastitis in cows is determined by an individual cow SCC being greater than a threshold.









DVG (Deutsche Veterinärmedizinische Gesellschaft [German Veterinary Association]). Leitlinien zur Bekämpfung der Mastitis des Rindes als Bestandsproblem [Guidelines for combating bovine mastitis as a herd problem], 2012, 5th edition. Gießen, Germany: Deutsche Veterinärmedizinische Gesellschaft (DVG).

Zadoks RN, Allore HG, Barkema HW, Sampimon OC, Gröhn YT, Schukken YH. Analysis of an Outbreak of Streptococcus uberis Mastitis. Journal of Dairy Science. 2001 Mar;84(3):590–9. doi:10.3168/jds.S0022-0302(01)74512-2.

Miller RH, Norman HD, Wiggans GR, Wright JR. Relationship of Test-Day Somatic Cell Score with Test-Day and Lactation Milk Yields. Journal of Dairy Science. 2004 Jul;87(7):2299–306. doi:10.3168/jds.S0022-0302(04)70051-X.

van den Borne BHP, Vernooij JCM, Lupindu AM, van Schaik G, Frankena K, Lam TJ, Nielen M. Relationship between somatic cell count status and subsequent clinical mastitis in Dutch dairy cows. Preventive Veterinary Medicine. 2011 Dec;102(4):265–73. doi: 10.1016/j.prevetmed.2011.07.013.

van den Borne BHP, van Schaik G, Lam TJGM, Nielen M, Frankena K. Intramammary antimicrobial treatment of subclinical mastitis and cow performance later in lactation. Journal of Dairy Science. 2019 May;102(5):4441–51. doi:10.3168/jds.2019-16254.

Barlow JW, Zadoks RN, Schukken YH. Effect of lactation therapy on Staphylococcus aureus transmission dynamics in two commercial dairy herds. BMC Veterinary Research. 2013 Jan 1;9(1):28–8. doi:10.1186/1746-6148-9-28.

Steeneveld W, Swinkels JM, Hogeveen H. Stochastic modelling to assess economic effects of treatment of chronic subclinical mastitis caused by Streptococcus uberis. Journal of Dairy Research. 2007 Oct 9;74(4):459–67. doi:10.1017/S0022029907002828.

van den Borne BHP, van Schaik G, Lam TJGM, Nielen M. Therapeutic effects of antimicrobial treatment during lactation of recently acquired bovine subclinical mastitis: Two linked randomized field trials. Journal of Dairy Science. 2010 Jan;93(1):218–33. doi: 10.3168/jds.2009-2567. PMID: 20059920.

van den Borne BHP, Halasa T, van Schaik G, Hogeveen H, Nielen M. Bioeconomic modeling of lactational antimicrobial treatment of new bovine subclinical intramammary infections caused by contagious pathogens. Journal of Dairy Science. 2010 Sep;93(9):4034–44. doi:10.3168/jds.2009-3030.

Rajala-Schultz P, Nødtvedt A, Halasa T, Persson Waller K. Prudent Use of Antibiotics in Dairy Cows: The Nordic Approach to Udder Health. Frontiers in Veterinary Science. 2021 Mar 5;8. doi:10.3389/fvets.2021.623998.

Barkema HW, Schukken YH, Zadoks RN. Invited Review: The Role of Cow, Pathogen, and Treatment Regimen in the Therapeutic Success of Bovine Staphylococcus aureus Mastitis. Journal of Dairy Science. 2006 Jun;89(6):1877–95. doi:10.3168/jds.S0022-0302(06)72256-1.

Barlow J. Mastitis Therapy and Antimicrobial Susceptibility: a Multispecies Review with a Focus on Antibiotic Treatment of Mastitis in Dairy Cattle. Journal of Mammary Gland Biology and Neoplasia. 2011 Oct 9;16(4):383–407. doi:10.1007/s10911-011-9235-z.

Ahlman T, Berglund B, Rydhmer L, Strandberg E. Culling reasons in organic and conventional dairy herds and genotype by environment interaction for longevity. Journal of Dairy Science. 2011 Mar;94(3):1568–75. doi:10.3168/jds.2010-3483.

Ruegg PL. Antibiotic treatments for bovine mastitis. American Association of Bovine Practitioners Conference Proceedings. 2013 Sep 19;72–8.

St Rose SG, Swinkels JM, Kremer WD, Kruitwagen CL, Zadoks RN. Effect of penethamate hydriodide treatment on bacteriological cure, somatic cell count and milk production of cows and quarters with chronic subclinical Streptococcus uberis or Streptococcus dysgalactiae infection. J Dairy Res. 2003;70(4):387-394. doi:10.1017/s0022029903006460.

Owens WE, Watts JL, Boddie RL, Nickerson SC. Antibiotic Treatment of Mastitis: Comparison of Intramammary and Intramammary Plus Intramuscular Therapies. Journal of Dairy Science. 1988 Nov;71(11):3143–7. doi:10.3168/jds.S0022-0302(88)79915-4.

Anonymous. 2009. Nordic guidelines for mastitis therapy. The NMSM Annual Conference June 12, Lund, Sweden https://www.sva.se/media/qsljw2yb/nordic-guidelines-for-mastitis-therapy.pdf.

Anonymous. 2017. Guidelines for the use of antibiotics in production animals. Cattle, pigs, sheep and goats. The Swedish Veterinary Association, Stockholm, Sweden. SVS guidelines 2017.indd (svf.se).

National Veterinary Institute (SVA). Recommandations for dry cow therapy with antibiotics. 2021. http://juverportalen.se/media/1249/recommendations-for-dry-cow-therapy-with-antibiotics-210615.pdf.

Barlow JW, White LJ, Zadoks RN, Schukken YH. A mathematical model demonstrating indirect and overall effects of lactation therapy targeting subclinical mastitis in dairy herds. Preventive Veterinary Medicine. 2009 Jul;90(1-2):31–42. doi:10.1016/j.prevetmed.2009.03.016.

Publicação de Resultados 2 0 2 1 [Internet]. [cited 2024 Feb 14]. Available from: https://www.ruralbit.com/client_manager/files/1661941681-1903.pdf.

David V, Beaugrand F, Gay E, Bastien J, Ducrot C. Evolution of antimicrobial usages in dairy and beef cattle industries: state of progress and prospects. INRAE Productions Animales. 2019 Apr 16;291–304. doi:10.20870/productions-animales.2019.32.2.2469.

Samson O, Gaudout N, Schmitt E, Schukken YH, Zadoks R. Use of on-farm data to guide treatment and control mastitis caused by Streptococcus uberis. Journal of Dairy Science. 2016 Sep;99(9):7690–9. doi:10.3168/jds.2016-10964.

GB milk hygiene | AHDB [Internet]. ahdb.org.uk. Available from: https://ahdb.org.uk/dairy/gb-milk-hygiene.

Slika na naslovnici: Kmetija Stopar, krave cike Foto: Franci Stopar, osebni arhiv [Internet]. [cited 2024 Feb 14]. Available from: https://www.govedo.si/wp-content/uploads/2022/08/POROCILO_2021.pdf.

Sadar M, Jeretina J, Logar B, Opara A, Pečnik Ž, Perpar T, Podgoršek P. Rezultati kontrole prireje mleka in mesa Slovenija 2021/Results of Dairy and Beef Recording Slovenia 2021., Ljubljana: Kmetijski inštitut Slovenije (2022). www.govedo.si.